GlassScriptPhysician profile
Lester Hubble
NPI 1831761410
$1,413.45
in general payments reported to CMS, 2019-2025
11 companies · $667 in 2025
The $667 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $173 · 2023: $99.16 · 2024: $474 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $360.33 | 2024-2025 | Lithovue, Rezum Generator, Spaceoar Vue System - 10ml |
| Coloplast Corp | $237.02 | 2023-2025 | Speedicath |
| Karl Storz Endoscopy-America | $203.14 | 2022-2024 | N.A. |
| Urogen Pharma, INC. | $171.54 | 2025 | |
| Calyxo, INC. | $145.71 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Abbvie INC. | $70.39 | 2025 | Lupron Depot |
| 180 Medical, INC. | $60.95 | 2025 | |
| Photocure INC | $32.77 | 2022 | |
| Medtronic, INC. | $16.58 | 2023 | Interstim |
| Sumitomo Pharma America, INC. | $15.03 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lester Hubble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.